Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin

Detalles Bibliográficos
Autores principales: Masuda, Daisaku, Yamashita, Shizuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406402/
https://www.ncbi.nlm.nih.gov/pubmed/32009076
http://dx.doi.org/10.5551/jat.ED124
_version_ 1783567412023525376
author Masuda, Daisaku
Yamashita, Shizuya
author_facet Masuda, Daisaku
Yamashita, Shizuya
author_sort Masuda, Daisaku
collection PubMed
description
format Online
Article
Text
id pubmed-7406402
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-74064022020-08-19 Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin Masuda, Daisaku Yamashita, Shizuya J Atheroscler Thromb Editorial Japan Atherosclerosis Society 2020-07-01 /pmc/articles/PMC7406402/ /pubmed/32009076 http://dx.doi.org/10.5551/jat.ED124 Text en 2020 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Editorial
Masuda, Daisaku
Yamashita, Shizuya
Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
title Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
title_full Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
title_fullStr Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
title_full_unstemmed Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
title_short Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
title_sort postprandial glucose and triglyceride increases along with the endothelial malfunction were attenuated by the administration of sglt2 inhibitor, empagliflozin
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406402/
https://www.ncbi.nlm.nih.gov/pubmed/32009076
http://dx.doi.org/10.5551/jat.ED124
work_keys_str_mv AT masudadaisaku postprandialglucoseandtriglycerideincreasesalongwiththeendothelialmalfunctionwereattenuatedbytheadministrationofsglt2inhibitorempagliflozin
AT yamashitashizuya postprandialglucoseandtriglycerideincreasesalongwiththeendothelialmalfunctionwereattenuatedbytheadministrationofsglt2inhibitorempagliflozin

Ejemplares similares